Navigation Links
Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
Date:4/22/2008

Company also announces Award of a National Institutes of Health Small Business Innovative Research (SBIR) Grant to support the Phase 2 Trial

HOUSTON, April 22 /PRNewswire/ -- Agennix, Inc. announced today that it has initiated a randomized, double-blind, placebo-controlled Phase 2 study of oral talactoferrin alfa in patients with severe sepsis. This is the first clinical trial of talactoferrin in sepsis and is based on both the mechanism of action of talactoferrin, and promising preclinical data demonstrating a significant reduction in mortality by talactoferrin in a variety of animal models of sepsis, including some that cause 100% mortality in untreated animals. The Phase 2 trial, which has started enrollment, will be conducted at approximately 25 leading U.S. centers with investigators who are very experienced in conducting trials in severe sepsis.

The study is being supported by a Small Business Innovative Research (SBIR) grant awarded from the National Institutes of Health (NIH). The total amount of the grant, $3 million, will provide the financial resources necessary to conduct the 190-patient study, which is designed to evaluate the safety and activity of talactoferrin in patients with severe sepsis. Results from the trial are anticipated in mid-2009.

"The number of sepsis-related deaths is on the rise, in spite of available treatment options," said Kalpalatha K. Guntupalli, M.D., Professor of Medicine, Chief of Pulmonary, Critical Care, and Sleep Medicine at Baylor College of Medicine and the Principal Investigator for the Phase 2 study. "Talactoferrin is a very promising compound with broad immunomodulatory and anti-inflammatory properties. The preclinical data in sepsis are very exciting, with talactoferrin demonstrating reductions in mortality rates of 50 percent or more in various animal models. We hope that the preclinical results translate to the drug showing activity in the Phase 2 study by reducing the number of deaths i
'/>"/>

SOURCE Agennix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
2. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
3. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
6. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
7. Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
8. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
11. Metabolex Initiates Phase 1 Trial of MBX-2982
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CVS Health Corporation (NYSE: CVS ) ... 1, 2015, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call will ... the CVS Health website for all interested parties. To ... will be archived and available on the web site ...
(Date:4/17/2015)... SAN DIEGO , April 17, 2015 /PRNewswire/ ... molecular diagnostics, announced today that clinical data presented ... demonstrate that its urine-based Precision Cancer Monitoring ℠ ... detection and monitoring of EGFR T790M ... titled Detection of EGFR T790M Mutation in ...
(Date:4/17/2015)... 2015  Over the next five years, the marijuana industry ... ArcView predicting that 14 more states will legalize recreational marijuana ... market for legal cannabis grew 74 percent in 2014 to ... the market could grow more than fourfold to $11 billion ... stance on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... discovery of two explosive devices at East Midlands and Dubai ... the aviation networks by terrorism. One of the bombs posted ... before being seized in Dubai, Qatar Airways has said. The ... Doha. It contained the powerful explosive PETN, which is difficult ...
... Medisafe 1 Technologies, Presentation on Newly Launched Company Website -- JERUSALEM, November 8, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Marken Rapidly Responds to Global Supply Chain Security Measures 2Medisafe 1 Technologies' Presentation on Newly Launched Company Website 2Medisafe 1 Technologies' Presentation on Newly Launched Company Website 3Medisafe 1 Technologies' Presentation on Newly Launched Company Website 4Medisafe 1 Technologies' Presentation on Newly Launched Company Website 5Medisafe 1 Technologies' Presentation on Newly Launched Company Website 6Medisafe 1 Technologies' Presentation on Newly Launched Company Website 7Medisafe 1 Technologies' Presentation on Newly Launched Company Website 8
(Date:4/19/2015)... 19, 2015 Women’s Excellence , ... Metamora (Michigan), now offers pelvic organ prolapse treatment. ... connecting tissue (fascia), and thickened pieces of fascia that ... the fascia and ligaments have to bear the brunt ... allowing pelvic organs to drop and press into the ...
(Date:4/19/2015)... The American Association for Physician Leadership® ... the inaugural winner of the Roger Schenke Award. The ... 18, in Las Vegas, Nevada. , Ellner, president ... the department of surgery and director of surgical quality ... Connecticut, was instrumental in the founding of the Connecticut ...
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... arrested for DUI. The blog post also discusses the ... , Some pills can have dangerous side effects ... are under medication should ask their doctor’s advice before ... be considered driving under the influence and clients can ...
(Date:4/19/2015)... New court documents issued by the ... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) continue to mount in ... of South Carolina. According to the April 15th filing, ... the proceeding on behalf of individuals who allegedly developed ... cholesterol-lowering statin. This represents an increase of 110 filings ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 McCann Investigations, ... to announce the publication of white paper Married, ... . As online media provides a unique environment ... niche market specifically targeting adulterous spouses has emerged. ... affair becomes as easy as shopping online. Dating ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers Pelvic Organ Prolapse Treatment 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2
... has negatively affected the treatment received by children and adolescents ... The meeting was hosted in association with the European Society ... hurdles faced by patients and those who care for them ... The Directive (2001/20/EC) has been one of the most ...
... 2012) The Scott & White Heart & Vascular Institute ... of Approval as a hospital performing Ventricular Assist Device ... permanent support for end stage heart failure by means ... the program demonstrated compliance with The Joint Commission,s national ...
... Gordon HealthDay Reporter , TUESDAY, Feb. 14 ... doesn,t speed recovery, new research shows. "We did ... diagnosis of acute sinusitis, and found no benefit from ... of acute sinusitis," said study author Dr. Jane Garbutt, ...
... , TUESDAY, Feb. 14 (HealthDay News) -- People who drank ... to 5 pounds over half a year, according to new ... divided into three groups: those who switched to water from ... those who weren,t advised to change beverages but were given ...
... , Blood tests have been a mainstay of diagnostic ... of information concerning health and disease. Nevertheless, blood derived ... fully mined for its vital health information, according to ... Institute. In a new study appearing in the ...
... in the field of Physical Anthropology. She not only ... Czech Republic, but she is also the Chair of ... the Department of Genetics, Physical Anthropology and Animal Physiology ... carried out numerous pieces of work into nutritional habits, ...
Cached Medicine News:Health News:Calls for policy changes as lives put at risk by bureaucracy 2Health News:Calls for policy changes as lives put at risk by bureaucracy 3Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 2Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 3Health News:Switching to Water, Diet Drinks Linked to Modest Weight Loss 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3
... you into the new age of non-surgical ... your patients immediate, long-term results for various ... injectable filler offers superior versatility for a ... treatments. Long-lasting, Radiesse saves time and money ...
... proven to reduce the appearance of cellulite ... combines Retinol, the purest form of Vitamin ... works deep within skin's surface to improve ... Fast absorbing, it has a fresh, clean ...
... proven aminophylline directly to the area most ... with the aminophylline containing cream has shown ... in the firmness of the thighs. Aminophylline ... where it causes the body fat cells ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
Medicine Products: